Results 281 to 290 of about 64,621 (307)

[Neoadjuvant and adjuvant therapy of ductal pancreatic carcinoma].

Zentralblatt fur Chirurgie, 2000
The optimal oncological management of ductal pancreatic cancer remains undefined. More than 60% of these patients have disseminated disease at the time of presentation. Here radical surgery alone cannot guarantee a cure. Even in the best case of a R0-resection with extended lymph node dissection the reported 5-year survival rates of 20-30% are ...
W, Hohenberger, S, Kastl
openaire   +1 more source

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cell, 2021
Liwei Cao, Chen Huang, Daniel Cui Zhou
exaly  

Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors

Diagnostics, 2021
Jun Ushio, Atsushi Kanno, Norikatsu Numao   +2 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, Linda C Chu, William L Hwang   +2 more
exaly  

Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer

International Journal of Molecular Sciences, 2023
Louis Marstrand-Daucé, Diane Lorenzo, Cecile Haumaitre   +2 more
exaly  

Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells

Cell Stem Cell, 2021
Markus Breunig, Martin Wagner, Michael Karl Melzer   +2 more
exaly  

Pancreatic Ductal Carcinoma

2016
openaire   +1 more source

Pancreatic Ductal Carcinoma

2015
openaire   +1 more source

Pancreatic Ductal Carcinoma

2018
openaire   +1 more source

Dilemma of pancreatic ductal carcinoma.

The American journal of gastroenterology, 1979
L, Weingarten, A M, Gelb, M G, Fischer
openaire   +1 more source